Cargando…

Therapeutic Potential of Novel Mastoparan-Chitosan Nanoconstructs Against Clinical MDR Acinetobacter baumannii: In silico, in vitro and in vivo Studies

PURPOSE: Acinetobacter baumannii antibiotic resistant infections in high-risk patients are a great challenge for researchers and clinicians worldwide. In an effort to achieve potent bactericidal outcomes, a novel chitosan–mastoparan nanoconstruct (Mast-Cs NC) was designed and assessed for its therap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hassan, Afreenish, Ikram, Aamer, Raza, Abida, Saeed, Sidra, Zafar Paracha, Rehan, Younas, Zumara, Khadim, Muhammad Tahir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179793/ https://www.ncbi.nlm.nih.gov/pubmed/34103914 http://dx.doi.org/10.2147/IJN.S296717

Ejemplares similares

Pangenome and immuno-proteomics analysis of Acinetobacter baumannii strains revealed the core peptide vaccine targets
por: Hassan, Afreenish, et al.
Publicado: (2016)

Efficacy of Mastoparan-AF alone and in combination with clinically used antibiotics on nosocomial multidrug-resistant Acinetobacter baumannii
por: Lin, Chun-Hsien, et al.
Publicado: (2017)

Virulence Potential and Treatment Options of Multidrug-Resistant (MDR) Acinetobacter baumannii
por: Kumar, Sunil, et al.
Publicado: (2021)

A Computational Systems Analyses to Identify Biomarkers and Mechanistic Link in Psoriasis and Cutaneous Squamous Cell Carcinoma
por: Adil, Sidra, et al.
Publicado: (2021)

Risk Factors and Drug Resistance of the MDR Acinetobacter Baumannii in Pneumonia Patients in ICU
por: Ren, Jichen, et al.
Publicado: (2019)

Computationally Designed AMPs with Antibacterial and Antibiofilm Activity against MDR Acinetobacter baumannii
por: Alsaab, Fahad M., et al.
Publicado: (2023)

Colistin Resistance in Acinetobacter baumannii MDR-ZJ06 Revealed by a Multiomics Approach
por: Hua, Xiaoting, et al.
Publicado: (2017)

Theoretical and Experimental Studies of Phosphonium Ionic Liquids as Potential Antibacterials of MDR Acinetobacter baumannii
por: Metelytsia, Larysa O., et al.
Publicado: (2022)

Differential Gene Expression of Efflux Pumps and Porins in Clinical Isolates of MDR Acinetobacter baumannii
por: AlQumaizi, Khalid I., et al.
Publicado: (2022)

715. Bulgecin A lowers Imipenem MICs in Clinical MDR Acinetobacter baumannii (ACB) Strains
por: Skalweit, Marion J, et al.
Publicado: (2019)

Drugs with new lease of life as quorum sensing inhibitors: for combating MDR Acinetobacter baumannii infections
por: Seleem, Noura M., et al.
Publicado: (2020)

Antibiotics Combinations and Chitosan Nanoparticles for Combating Multidrug Resistance Acinetobacter baumannii
por: Banoub, Nancy G, et al.
Publicado: (2021)

Community acquired multi drug resistant (MDR) Acinetobacter baumannii pneumonia in Malaysia – A case report
por: Mohd, Rozita, et al.
Publicado: (2018)

Immunoprotective potential of BamA, the outer membrane protein assembly factor, against MDR Acinetobacter baumannii
por: Singh, Ravinder, et al.
Publicado: (2017)

Colonization of long term care facility patients with MDR-Gram-negatives during an Acinetobacter baumannii outbreak
por: Zollner-Schwetz, Ines, et al.
Publicado: (2017)

Thermoresponsive Magnetic Hydrogels as Theranostic Nanoconstructs
por: Jaiswal, Manish K., et al.
Publicado: (2014)

X-ray-Activatable Photodynamic Nanoconstructs
por: Overchuk, Marta, et al.
Publicado: (2020)

Characterization of Two Novel Bacteriophages Infecting Multidrug-Resistant (MDR) Acinetobacter baumannii and Evaluation of Their Therapeutic Efficacy in Vivo
por: Cha, Kyoungeun, et al.
Publicado: (2018)

Pharmacokinetic-pharmacodynamic modelling to investigate in vitro synergy between colistin and fusidic acid against MDR Acinetobacter baumannii
por: Phee, Lynette M, et al.
Publicado: (2019)

CLSI based antibiogram profile and the detection of MDR and XDR strains of Acinetobacter baumannii isolated from urine samples
por: Girija AS, Smiline, et al.
Publicado: (2019)

Using WGS to identify antibiotic resistance genes and predict antimicrobial resistance phenotypes in MDR Acinetobacter baumannii in Tanzania
por: Kumburu, Happiness H, et al.
Publicado: (2019)

In vivo bactericidal effect of colistin–linezolid combination in a murine model of MDR and XDR Acinetobacter baumannii pneumonia
por: Ma, Xiao-Lin, et al.
Publicado: (2020)

In Silico Analysis of SARS-CoV-2 Spike Proteins of Different Field Variants
por: Haseeb, Muhammad, et al.
Publicado: (2023)

Corrigendum: Characterization of Two Novel Bacteriophages Infecting Multidrug-Resistant (MDR) Acinetobacter baumannii and Evaluation of Their Therapeutic Efficacy in vivo
por: Cha, Kyoungeun, et al.
Publicado: (2022)

Tackling Acinetobacter baumannii
por: Granata, Guido, et al.
Publicado: (2023)

Antibacterial Effect of Chitosan-Modified Fe(3)O(4) Nanozymes on Acinetobacter baumannii
por: Wenjun, Wang, et al.
Publicado: (2022)

In silico evaluation of molecular virus–virus interactions taking place between Cotton leaf curl Kokhran virus- Burewala strain and Tomato leaf curl New Delhi virus
por: Ali, Nida Fatima, et al.
Publicado: (2021)

Identification of antibiotic resistance genes in the multidrug-resistant Acinetobacter baumannii strain, MDR-SHH02, using whole-genome sequencing
por: Wang, Hualiang, et al.
Publicado: (2017)

The emergence of a novel sequence type of MDR Acinetobacter baumannii from the intensive care unit of an Egyptian tertiary care hospital
por: Ghaith, Doaa Mohammad, et al.
Publicado: (2017)

In-Silico Vaccine Design Based on a Novel Vaccine Candidate Against Infections Caused by Acinetobacter baumannii
por: Khalid, Kashaf, et al.
Publicado: (2021)

In Silico and In Vitro Structure–Activity Relationship of Mastoparan and Its Analogs
por: Rungsa, Prapenpuksiri, et al.
Publicado: (2022)

Oligochitosan-stabilized photoluminescent gold nanoconstructs for optical bioimaging
por: Yoo, Donghyuck, et al.
Publicado: (2017)

Bimodular Antiparallel G-Quadruplex Nanoconstruct with Antiproliferative Activity
por: Antipova, Olga, et al.
Publicado: (2019)

Multidrug-Resistant Acinetobacter baumannii
por: Abbo, Aharon, et al.
Publicado: (2005)

Multidrug-Resistant Acinetobacter baumannii
por: Krcmery, Vladimir, et al.
Publicado: (2007)

Diagnosis of Acinetobacter Baumannii Infections
por: Gozdas, Hasan T
Publicado: (2012)

Acinetobacter baumannii—The New MRSA?
por: Barrie, Alasdair, et al.
Publicado: (2016)

Glycosphingolipids Recognized by Acinetobacter baumannii
por: Madar Johansson, Miralda, et al.
Publicado: (2020)

Subunit vaccines for Acinetobacter baumannii
por: Yang, Ning, et al.
Publicado: (2023)

An MFS Transporter-Like ORF from MDR Acinetobacter baumannii AIIMS 7 Is Associated with Adherence and Biofilm Formation on Biotic/Abiotic Surface
por: Sahu, Praveen K., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_t6eagh0np0e08sv91ao6hr6kgk